1984
DOI: 10.1007/bf00257129
|View full text |Cite
|
Sign up to set email alerts
|

Potentiation by amphotericin B of the cytotoxicity of anticancer agents against MOPC-315 plasmacytoma and lewis lung carcinoma

Abstract: The ability of amphotericin B (AmB) to potentiate the cytotoxicity of several different anticancer agents against two murine tumor models was examined. A spleen colony assay was used to quantitate the cytotoxicity of BCNU, CCNU, and L-PAM, either alone or in combination with AmB against the MOPC-315 plasmacytoma. A high level of potentiation of the effects of CCNU and L-PAM by AmB occurred, but AmB did not increase the cytotoxicity of BCNU. Tumor growth curves and calculation of cell survival demonstrated sign… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

1986
1986
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 3 publications
0
4
0
Order By: Relevance
“…Furthermore they may also act in synergy with other drugs, such as anticancer or antiviral compounds [62,63]. The pentaene faeriefungin is a broad-spectrum antibiotic active against fungi, bacteria, nematodes and mosquito larvae [64].…”
Section: Mode Of Actionmentioning
confidence: 99%
“…Furthermore they may also act in synergy with other drugs, such as anticancer or antiviral compounds [62,63]. The pentaene faeriefungin is a broad-spectrum antibiotic active against fungi, bacteria, nematodes and mosquito larvae [64].…”
Section: Mode Of Actionmentioning
confidence: 99%
“…Significance was determined using one-way ANOVA followed by Tukey's multiple comparisons test, with p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), p < 0.0001 (****). A version of the Valeriote and Lin model was applied for calculation of expected additive combination effects of spheroids and has been described previously [ 32 ]. In short, effects of the combination of sorafenib and 131 I-AbN44v6 were analyzed, using a version of the ‘additive model’.…”
Section: Methodsmentioning
confidence: 99%
“…If the actually observed SF of the combination is lower, the two treatments interact supra-additively. This basic equation was previously employed to assess potential supra-additive interactions of cytotoxic treatments 29,30 and was recently applied to combinations of TTFields and RT 19,21 or chemotherapy. 23 Similar to, 23 we descriptively compared the real SF curve to the expected additive effect curve to classify treatment interactions.…”
Section: Combination Experimentsmentioning
confidence: 99%